# EDGAR Filing Document

**Accession Number:** 0001337013
**File Stem:** 0001628280-26-018216
**Filing Date:** 2026-3
**Character Count:** 11333
**Document Hash:** b6746449b4045404fe27f83e35571707
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-018216.hdr.sgml**: 20260316

**ACCESSION NUMBER**: 0001628280-26-018216

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260316

**ITEM INFORMATION**: Regulation FD Disclosure

**FILED AS OF DATE**: 20260316

**DATE AS OF CHANGE**: 20260316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** InfuSystem Holdings, Inc
- **CENTRAL INDEX KEY:** 0001337013
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 203341405
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35020
- **FILM NUMBER:** 26757267

**BUSINESS ADDRESS:**
- **STREET 1:** 3851 WEST HAMLIN ROAD
- **CITY:** ROCHESTER HILLS
- **STATE:** MI
- **ZIP:** 48309
- **BUSINESS PHONE:** (248) 291-1210

**MAIL ADDRESS:**
- **STREET 1:** 3851 WEST HAMLIN ROAD
- **CITY:** ROCHESTER HILLS
- **STATE:** MI
- **ZIP:** 48309

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HAPC, Inc.
- **DATE OF NAME CHANGE:** 20060425

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Healthcare Acquisition Partners Corp.
- **DATE OF NAME CHANGE:** 20050824

?xml version='1.0' encoding='ASCII'? infu-20260316

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**___________________________________**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**Date of Report (date of earliest event reported): March 16, 2026**

**___________________________________**

**InfuSystem Holdings, Inc.**

(Exact name of registrant as specified in its charter)

**___________________________________**

---

| | | |
|:---|:---|:---|
| **Delaware**<br>(State or other jurisdiction of <br>incorporation or organization) | **001-35020**<br>(Commission File Number) | **20-3341405**<br>(I.R.S. Employer Identification Number) |
| **3851 West Hamlin Road**<br>**Rochester Hills, Michigan 48309** | **3851 West Hamlin Road**<br>**Rochester Hills, Michigan 48309** | **3851 West Hamlin Road**<br>**Rochester Hills, Michigan 48309** |
| &nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices) (Zip Code) | &nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices) (Zip Code) | &nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices) (Zip Code) |
| **(248) 291-1210** | **(248) 291-1210** | **(248) 291-1210** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |
|  | **Not Applicable** |  |
| (Former Name or Former Address, if Changed Since Last Report) | (Former Name or Former Address, if Changed Since Last Report) | (Former Name or Former Address, if Changed Since Last Report) |

---

**___________________________________**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

**☐** Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

**☐** Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

**☐** Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

**☐** Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Title of Each Class** | **Trading Symbol(s)** | **Name of Each Exchange on which Registered** |
| **Common Stock, par value $.0001 per share** | **INFU** | **NYSE American LLC** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 7.01 - Regulation FD Disclosure**

On March 16, 2026, InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that Carrie Lachance, President and Chief Executive Officer, and Barry Steele, Chief Financial Officer, will participate in the 38th Annual ROTH Conference on Monday, March 23, 2026. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

**Item 9.01 - Financial Statements and Exhibits**

**(d) Exhibits**

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>Description</u>** |
| <u>[99.1](exhibit9913-16x2026rothcon.htm)</u> | <u>[Press Release of InfuSystem Holdings, Inc. dated March 16, 2026](exhibit9913-16x2026rothcon.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| INFUSYSTEM HOLDINGS, INC. | INFUSYSTEM HOLDINGS, INC. |
| By: | /s/ Barry Steele |
|  | Barry Steele |
|  | Chief Financial Officer |

---

Dated: March 16, 2026

## Exhibit 99.1

Exhibit 99.1

---

| | | |
|:---|:---|:---|
| ![infusystem_safesmarttruste.jpg](infusystem_safesmarttruste.jpg) | **InfuSystem Holdings, Inc.**<br>3851 W. Hamlin Road<br>Rochester Hills, MI 48309<br>(248) 291-1210 | **Contact:**<br>Barry Steele<br>Chief Financial Officer<br>(248) 260-2211 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

**InfuSystem to Participate at 38th Annual ROTH Conference**

**on March 23, 2026**

**Rochester Hills, Michigan,** March 16, 2026 - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Carrie Lachance, President and Chief Executive Officer and Barry Steele, Chief Financial Officer, will participate in the 38<sup>th</sup> Annual ROTH Conference on Monday, March 23, 2026. The conference will be held at The Ritz-Carlton Laguna Niguel in Dana Point, California.

Management is scheduled to host in-person one-on-one meetings held throughout the day. Investors interested in arranging one-on-one meetings with InfuSystem should contact their ROTH Capital conference representative or submit a registration request by visiting https://ibn.fm/Roth2026Registration.

***About InfuSystem Holdings, Inc.***

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.

***Forward-Looking Statements***

*Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, business plans, strategic partnerships, growth initiatives, objectives and prospects, future operating or financial performance, guidance and expected new business relationships and the terms thereof (including estimated potential revenue under new or existing contracts). The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "goal," "expect," "strategy," "future," "likely," variations of such words, and other similar* 

------

*expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to factors, risks and uncertainties that could cause actual results to differ materially, including, but not limited to, our ability to successfully execute on our growth initiatives and strategic partnerships, our ability to enter into definitive agreements for new business relationships on expected terms or at all, our ability to generate estimated potential revenue amounts under new or existing contracts, our dependence on estimates of collectible revenue, potential litigation, changes in third-party reimbursement processes, changes in law, global financial conditions and recessionary risks, rising inflation and interest rates, supply chain disruptions, systemic pressures in the banking sector, including disruptions to credit markets, the Company's ability to remediate its previously disclosed material weakness in internal control over financial reporting, contributions from acquired businesses or new business lines, products or services and other risk factors disclosed in the Company's most recent annual report on Form 10-K and, to the extent applicable, quarterly reports on Form 10-Q. Our strategic partnerships are subject to similar factors, risks and uncertainties. All forward-looking statements made in this press release speak only as of the date hereof. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances, except as required by law.*

*Additional information about InfuSystem Holdings, Inc. is available at <u>www.infusystem.com</u>.*

####

<br>